<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In previous studies, we identified rhomboid domain containing 2 (RHBDD2) gene to be markedly overexpressed in <z:hpo ids='HP_0003002'>breast cancer</z:hpo> patients that developed recurrence of the disease </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we evaluated for the first time RHBDD2 gene expression in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>Five public available DNA microarray studies were compiled in a homogeneous dataset of 906 colorectal samples </plain></SENT>
<SENT sid="3" pm="."><plain>The statistical analysis of these data showed a significant increase of RHBDD2 expression in the advanced stages of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (p &lt; 0.01) </plain></SENT>
<SENT sid="4" pm="."><plain>We validated these findings by immunohistochemistry on 130 colorectal tissue samples; RHBDD2 protein overexpression was also observed in the advanced stages of the disease (p &lt; 0.001) </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, we investigated RHBDD2 expression in response to the chemotherapy agent 5-fluorouracile (5FU) </plain></SENT>
<SENT sid="6" pm="."><plain>We detected a significant increase of RHBDD2 <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein after 5FU treatment (20-40 Î¼M; p &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>Overall, these results showed that RHBDD2 overexpression might play a role in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> progression </plain></SENT>
</text></document>